Dear Patient,
Was a magnesium load test done on you? Was a glucose tolerance test done?
Did anybody go over your diet? Is there any history of diabetes in your
family? What about your attitudes towards exercise? What are the major
sources of stress in your life? These factors and many more may affect
seizure activity risk thresholds, nutritional supplement/drug intake
thresholds, their ceiling of activity. How thorough was the workup that
was done on you?
I suggest that you explore the role of magnesium-taurate in the treatment
and management of electrochemical disturbances and in seizure disorders in
lieu of or in addition to regular seizure medications, possibly to lower
both the loading and maintenance dose pharmaceutical requirements.
Specialized dose-response curves have to be developed with you on the
1. magnesium (via mg load test)
2. Other electrolytes to maintain electrochemical stability
3. L-taurine
4. pharmaceutical management (drugs)
You have specialized, individualized electrochemical thresholds and
"ceilings of activity" unlike other seizure disorder type patients. Don't
be lumpted together with everybody else. You are very special. A
"patient-centered diagnostic approach" that combines a creative clinician
with a resourceful patient is a great combination.
Uses of magnesium and L-Taurine are vastly underused in mainstream clinical
medicine in the management of seizure type disorders. Also, agressive fluid
and electrolyte managment is part of this complimentary approach, as well.
I use a "patient-centered diagnostic" (PCD) approach that extensively
databases the patient, including lab tests that might reveal a number of
other undiscovered factors that may cause/precipitate/exaccerbate seizure
activity such as stress or uncontrolled/poorly controlled blood sugar. A
good approach is to identify all of the possible factors first and use a
prescription pad, last. Looking at and controlling the other seizure risk
factors (especially magnesium-taurate) allows the clinician and patient to
use smaller amounts of the drugs both in drug loading and maintenance
dosages.
